Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle

Z Xiong1, A Shaibani, Y-P Li

  • 1Laboratory of Immunopathology, Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA.

Summary

Alternative splicing factor 2 (ASF/SF2) is reduced in inflammatory myositis. Tumor necrosis factor alpha (TNFalpha) may mediate this downregulation, offering new therapeutic targets for autoimmune muscle diseases.